Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-25 @ 12:39 AM
Ignite Modification Date: 2025-12-25 @ 10:49 PM
NCT ID: NCT01313767
Description: All AEs reported during the study period were tabulated and AE incidence was determined.
Frequency Threshold: 2
Time Frame: The subjects were observed every visit after signing an Informed consent form (visit 1) until 12 weeks post injection
Study: NCT01313767
Study Brief: MEDITOXIN® Versus BOTOX® in the Treatment of Post-stroke Spasticity of the Upper Limb Spasticity
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Botox® Botulinum Toxin type A None None 8 98 35 98 View
Meditoxin® Botulinum toxin type A None None 5 98 35 98 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Cholecystitis acute SYSTEMATIC_ASSESSMENT Hepatobiliary disorders MedDRA(ver. 14.0) View
Inguinal hernia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA(ver. 14.0) View
Muscular weakness SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA(ver. 14.0) View
Pneumonia SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA(ver. 14.0) View
Renal failure SYSTEMATIC_ASSESSMENT Renal and urinary disorders MedDRA(ver. 14.0) View
Hepatitis toxic SYSTEMATIC_ASSESSMENT Hepatobiliary disorders MedDRA(ver. 14.0) View
Intraventricular haemorrhage SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA(ver. 14.0) View
Convulsion SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA(ver. 14.0) View
Pyelonephritis acute SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA(ver. 14.0) View
Fall SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA(ver. 14.0) View
Femoral neck fracture SYSTEMATIC_ASSESSMENT Injury, poisoning and procedural complications MedDRA(ver. 14.0) View
Behcet's syndrome SYSTEMATIC_ASSESSMENT Immune system disorders MedDRA(ver. 14.0) View
Pulmonary tuberculosis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA(ver. 14.0) View
Myocardial infarction SYSTEMATIC_ASSESSMENT Cardiac disorders MedDRA(ver. 14.0) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Diarrhoea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA(ver. 14.0) View
Vomiting SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA(ver. 14.0) View
Abdominal distension SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA(ver. 14.0) View
Dyspepsia SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA(ver. 14.0) View
Consitipation SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA(ver. 14.0) View
Nasopharyngitis SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA(ver. 14.0) View
Upper respiratory tract infection SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA(ver. 14.0) View
Pain in extremity SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA(ver. 14.0) View
Back pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA(ver. 14.0) View
Musculoskeletal pain SYSTEMATIC_ASSESSMENT Musculoskeletal and connective tissue disorders MedDRA(ver. 14.0) View
Oedema peripheral SYSTEMATIC_ASSESSMENT General disorders MedDRA(ver. 14.0) View
Injection site haematoma SYSTEMATIC_ASSESSMENT General disorders MedDRA(ver. 14.0) View
Pyrexia SYSTEMATIC_ASSESSMENT General disorders MedDRA(ver. 14.0) View
Cough SYSTEMATIC_ASSESSMENT Respiratory, thoracic and mediastinal disorders MedDRA(ver. 14.0) View
Cholecystitis acute SYSTEMATIC_ASSESSMENT Hepatobiliary disorders MedDRA(ver. 14.0) View
Hyperlipidaemia SYSTEMATIC_ASSESSMENT Metabolism and nutrition disorders MedDRA(ver. 14.0) View
Convulsion SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA(ver. 14.0) View
Dizziness SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA(ver. 14.0) View
Headache SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA(ver. 14.0) View
Partial seizures SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA(ver. 14.0) View
Nausea SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA(ver. 14.0) View